310 related articles for article (PubMed ID: 22244853)
1. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
Griffin MD; Yeung L; Hung A; Todorova N; Mok YF; Karas JA; Gooley PR; Yarovsky I; Howlett GJ
J Mol Biol; 2012 Mar; 416(5):642-55. PubMed ID: 22244853
[TBL] [Abstract][Full Text] [Related]
2. "Janus" cyclic peptides: a new approach to amyloid fibril inhibition?
Todorova N; Yeung L; Hung A; Yarovsky I
PLoS One; 2013; 8(2):e57437. PubMed ID: 23437387
[TBL] [Abstract][Full Text] [Related]
3. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
Hung A; Griffin MD; Howlett GJ; Yarovsky I
J Phys Chem B; 2009 Jul; 113(28):9447-53. PubMed ID: 19537801
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulations of a fibrillogenic peptide derived from apolipoprotein C-II.
Legge FS; Treutlein H; Howlett GJ; Yarovsky I
Biophys Chem; 2007 Nov; 130(3):102-13. PubMed ID: 17825978
[TBL] [Abstract][Full Text] [Related]
5. Effect of oxidation and mutation on the conformational dynamics and fibril assembly of amyloidogenic peptides derived from apolipoprotein C-II.
Legge FS; Binger KJ; Griffin MD; Howlett GJ; Scanlon D; Treutlein H; Yarovsky I
J Phys Chem B; 2009 Oct; 113(42):14006-14. PubMed ID: 19780547
[TBL] [Abstract][Full Text] [Related]
6. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
[TBL] [Abstract][Full Text] [Related]
7. Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils.
Binger KJ; Griffin MD; Howlett GJ
Biochemistry; 2008 Sep; 47(38):10208-17. PubMed ID: 18729385
[TBL] [Abstract][Full Text] [Related]
8. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
Ryan TM; Griffin MD; Teoh CL; Ooi J; Howlett GJ
J Mol Biol; 2011 Feb; 406(3):416-29. PubMed ID: 21185302
[TBL] [Abstract][Full Text] [Related]
9. Shear flow induced changes in apolipoprotein C-II conformation and amyloid fibril formation.
Teoh CL; Bekard IB; Asimakis P; Griffin MD; Ryan TM; Dunstan DE; Howlett GJ
Biochemistry; 2011 May; 50(19):4046-57. PubMed ID: 21476595
[TBL] [Abstract][Full Text] [Related]
10. Lipid concentration effects on the amyloidogenic apoC-II(60-70) peptide: a computational study.
Todorova N; Hung A; Yarovsky I
J Phys Chem B; 2010 Jun; 114(23):7974-82. PubMed ID: 20496878
[TBL] [Abstract][Full Text] [Related]
11. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.
Stewart CR; Wilson LM; Zhang Q; Pham CL; Waddington LJ; Staples MK; Stapleton D; Kelly JW; Howlett GJ
Biochemistry; 2007 May; 46(18):5552-61. PubMed ID: 17429947
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen/Deuterium Exchange and Molecular Dynamics Analysis of Amyloid Fibrils Formed by a D69K Charge-Pair Mutant of Human Apolipoprotein C-II.
Mao Y; Zlatic CO; Griffin MD; Howlett GJ; Todorova N; Yarovsky I; Gooley PR
Biochemistry; 2015 Aug; 54(31):4805-14. PubMed ID: 26196342
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
[TBL] [Abstract][Full Text] [Related]
14. Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide.
Todorova N; Hung A; Maaser SM; Griffin MD; Karas J; Howlett GJ; Yarovsky I
Phys Chem Chem Phys; 2010 Nov; 12(44):14762-74. PubMed ID: 20938536
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in disease-related apolipoprotein C-II amyloid fibrils: a structural model for rod-like fibrils.
Zlatic CO; Mao Y; Todorova N; Mok YF; Howlett GJ; Yarovsky I; Gooley PR; Griffin MDW
FEBS J; 2018 Aug; 285(15):2799-2812. PubMed ID: 29791776
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of peptide aggregation by lipids: insights from coarse-grained molecular simulations.
Hung A; Yarovsky I
J Mol Graph Model; 2011 Feb; 29(5):597-607. PubMed ID: 21146432
[TBL] [Abstract][Full Text] [Related]
17. Intra- and Intersubunit Ion-Pair Interactions Determine the Ability of Apolipoprotein C-II Mutants To Form Hybrid Amyloid Fibrils.
Todorova N; Zlatic CO; Mao Y; Yarovsky I; Howlett GJ; Gooley PR; Griffin MD
Biochemistry; 2017 Mar; 56(12):1757-1767. PubMed ID: 28229588
[TBL] [Abstract][Full Text] [Related]
18. Visualization of polymorphism in apolipoprotein C-II amyloid fibrils.
Teoh CL; Yagi H; Griffin MD; Goto Y; Howlett GJ
J Biochem; 2011 Jan; 149(1):67-74. PubMed ID: 20889492
[TBL] [Abstract][Full Text] [Related]
19. Avoiding the oligomeric state: αB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils.
Binger KJ; Ecroyd H; Yang S; Carver JA; Howlett GJ; Griffin MD
FASEB J; 2013 Mar; 27(3):1214-22. PubMed ID: 23159935
[TBL] [Abstract][Full Text] [Related]
20. Charge and charge-pair mutations alter the rate of assembly and structural properties of apolipoprotein C-II amyloid fibrils.
Mao Y; Teoh CL; Yang S; Zlatic CO; Rosenes ZK; Gooley PR; Howlett GJ; Griffin MD
Biochemistry; 2015 Feb; 54(6):1421-8. PubMed ID: 25609257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
